ReviewFrontiers in public health2026
The impact of cardiometabolic multimorbidity on cognitive function in older adults: a review.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiometabolic multimorbidity (CMM) represents the most prevalent and most detrimental chronic disease comorbidity pattern for cognitive impairment, directly accelerating cognitive dysfunction and dementia progression. However, existing research predominantly investigates cognitive function in patients with single diseases or specific binary comorbidities, leaving significant gaps in understanding the cognitive domain among older adults with CMM. This review focuses on the impact of CMM on cognitive function in the older adults synthesizing perspectives on their correlation, underlying mechanisms, assessment tools, and risk factors. It aims to provide insights for screening high-risk populations and formulating management strategies to delay the risk of cognitive dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.